Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01659346
What this trial is testing

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
Not applicableStudy completedNCT01642446
What this trial is testing

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma(HCC)Cirrhotic Portal Hypertension
Sun Yat-sen University 160
Testing effectiveness (Phase 2)Study completedNCT02794805
What this trial is testing

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Meridian Bioscience, Inc. 74
Testing effectiveness (Phase 2)UnknownNCT02715362
What this trial is testing

GPC3 Redirected Autologous T Cells for Advanced HCC

Who this might be right for
Carcinoma, Hepatocellular
Shanghai GeneChem Co., Ltd. 30
Not applicableLooking for participantsNCT06905262
What this trial is testing

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 70
Early research (Phase 1)Active Not RecruitingNCT05546879
What this trial is testing

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 43
Not applicableWithdrawnNCT03748927
What this trial is testing

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04241523
What this trial is testing

Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 50
Not applicableLooking for participantsNCT06849180
What this trial is testing

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaCombined Hepatocellular Carcinoma and CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Zhongda Hospital 198
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00912847
What this trial is testing

Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

Who this might be right for
Hepatitis B Virus
Chinese University of Hong Kong 1,018
Testing effectiveness (Phase 2)Study completedNCT05007548
What this trial is testing

To Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

Who this might be right for
Hepatic Carcinoma
National Atomic Research Institute, Taiwan 30
Large-scale testing (Phase 3)Study completedNCT00908752
What this trial is testing

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 734
Testing effectiveness (Phase 2)Looking for participantsNCT05690048
What this trial is testing

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Who this might be right for
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill 48
Testing effectiveness (Phase 2)UnknownNCT04317248
What this trial is testing

"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 600
Early research (Phase 1)Study completedNCT02028949
What this trial is testing

Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study

Who this might be right for
Unresectable Non-metastatic Hepatocellular CarcinomaChild A/B7 Cirrhosis
Centre Hospitalier Universitaire Dijon 15
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT01479608
What this trial is testing

Liver Transplantation and Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastasis
Oslo University Hospital 25
Not applicableNot Yet RecruitingNCT07768085
What this trial is testing

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 40,000
Testing effectiveness (Phase 2)UnknownNCT05971199
What this trial is testing

Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 27
Next Page